Open access
Open access
Powered by Google Translator Translator

Recommendation Statement: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women

26 Dec, 2017 | 23:14h | UTC

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement – JAMA (free)

JAMA Editorials: Menopausal Hormone Therapy for Primary Prevention of Chronic Disease (free) AND Evidence for Postmenopausal Hormone Therapy to Prevent Chronic Conditions: Success, Failure, and Lessons Learned (free) AND Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: Unfulfilled Expectations (free)

Audio Interview: USPSTF Recommendation Statement: Hormone Therapy After Menopause (free)

Summary: Hormone Therapy Not Recommended for Prevention of Chronic Conditions in Postmenopausal Women – The JAMA Network (free)

“The U.S. Preventive Services Task Force (USPSTF) recommends against the use of combined estrogen and progestin in postmenopausal women, or estrogen alone in postmenopausal women who have had a hysterectomy, to prevent chronic conditions such as heart disease, dementia and stroke”.

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.